TAZ anticorps (AA 174-248)

N° du produit ABIN6148874

Cet anticorps anti-TAZ est un anticorps Lapin Polyclonal détectant TAZ dans WB. Adapté pour Humain.

Aperçu rapide pour TAZ anticorps (AA 174-248) (ABIN6148874)

Antigène: TAZ (Tafazzin (TAZ))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TAZ est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-TAZ anticorps

Épitope: AA 174-248

Séquence: NDVLPNSPPY FPRFGQKITV LIGKPFSALP VLERLRAENK SAVEMRKALT DFIQEEFQHL KTQAEQLHNH LQPGR

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 174-248 of human Tafazzin / TAZ (NP_851830.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:1000 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur TAZ

Antigène: TAZ (Tafazzin (TAZ))

Autre désignation: TAZ

Sujet: This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.,TAZ,BTHS,CMD3A,EFE,EFE2,G4.5,LVNCX,Taz1,tafazzin,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,TAZ

Poids moléculaire: 25 kDa/27 kDa/28 kDa/29 kDa/30 kDa/31 kDa/33 kDa

ID gène: 6901

UniProt: Q16635